| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/14/2011 | US20110171244 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof |
| 07/14/2011 | US20110171243 Compounds for treating amyloidoses |
| 07/14/2011 | US20110171242 Ligand for herpes simplex virus entry mediator and methods of use |
| 07/14/2011 | US20110171239 pH INDUCED SILK GELS AND USES THEREOF |
| 07/14/2011 | US20110171238 Novel stra6 polypeptides |
| 07/14/2011 | US20110171232 Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth |
| 07/14/2011 | US20110171230 Method of Identifying Agents that Promote Axonal Development |
| 07/14/2011 | US20110171228 Methods and Compositions Relating to the Regulation of Apoptosis by MUC1 and BH3-Containing Proapoptotic Proteins |
| 07/14/2011 | US20110171226 Novel Subtype of Closteridium Botulinum Neurotoxin Type A and Uses Thereof |
| 07/14/2011 | US20110171225 Novel Plasmodium Falciparum Gene Encoding Signal Peptide Peptidase and Method of Using Inhibitors Thereof for Inhibiting Malarial Infection |
| 07/14/2011 | US20110171219 Treating cancer stem cells using targeted cargo proteins |
| 07/14/2011 | US20110171212 Methods and compositions for preventing radiation-induced pneumonitis |
| 07/14/2011 | US20110171209 Potentiation of Autoimmune and Inflammatory Disease Treatments by Immune Regulatory Oligonucleotide (IRO) Antagonists of TLR7 and TLR9 |
| 07/14/2011 | US20110171205 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 07/14/2011 | US20110171202 Method of treating hearing loss using xiap |
| 07/14/2011 | US20110171201 Formulation for Oral Administration of Proteins |
| 07/14/2011 | US20110171200 Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound |
| 07/14/2011 | US20110171199 Method for reducing or eliminating pain associated with a post-operative wound |
| 07/14/2011 | US20110171198 Highly functional enzyme having alpha-galactosidase activity |
| 07/14/2011 | US20110171197 Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same |
| 07/14/2011 | US20110171196 Methods of treatment and uses for camkii and its interaction with hdacs and calpain |
| 07/14/2011 | US20110171195 Methods and compositions for treating urinary tract infections using agents that mimic or elevate cyclic amp |
| 07/14/2011 | US20110171194 METHODS AND COMPOSITIONS FOR INHIBITING ABAD/ABeta PROTEIN INTERACTION |
| 07/14/2011 | US20110171193 Compositions and methods for treating pulmonary hypertension |
| 07/14/2011 | US20110171192 Substituted amine derivative and medicinal composition comprising same as the active ingredient |
| 07/14/2011 | US20110171191 Suppression of neuroendocrine diseases |
| 07/14/2011 | US20110171190 Pharmacological vitreolysis |
| 07/14/2011 | US20110171189 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 07/14/2011 | US20110171188 Non-thermal plasma for wound treatment and associated apparatus and method |
| 07/14/2011 | US20110171187 Dietary supplements for promotion of growth, repair, and maintenance of bone and joints |
| 07/14/2011 | US20110171184 Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci) |
| 07/14/2011 | US20110171178 Compositions and methods of using proislet peptides and analogs thereof |
| 07/14/2011 | US20110171177 Compositions and Methods for Inhibiting Entry of a Hepatic Virus |
| 07/14/2011 | US20110171176 Complement antagonists and uses thereof |
| 07/14/2011 | US20110171175 Inhibitors of serine proteases |
| 07/14/2011 | US20110171174 Synergistic Combinations of a Macrocyclic Inhibitor of HCV and a Nucleoside |
| 07/14/2011 | US20110171173 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities |
| 07/14/2011 | US20110171172 Compounds for inhibiting ksp kinesin activity |
| 07/14/2011 | US20110171171 Bridged secondary amines and use thereof as iap bir domain binding compounds |
| 07/14/2011 | US20110171170 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide |
| 07/14/2011 | US20110171169 Peptides for active anti-cytokine immunization |
| 07/14/2011 | US20110171168 Human g-csf analogs and methods of making and using thereof |
| 07/14/2011 | US20110171164 Polymer conjugates of glp-2-like peptides |
| 07/14/2011 | US20110171161 Polymer conjugates of protegrin peptides |
| 07/14/2011 | US20110171159 Glycoside Derivatives and Uses Thereof |
| 07/14/2011 | US20110171144 Functional Micelles for Hard Tissue Targeted Delivery of Chemicals |
| 07/14/2011 | US20110171140 Absorption of therapeutic agents across mucosal membranes or the skin |
| 07/14/2011 | US20110171132 Methods, Compounds, and Compositions for Treatment and Prophylaxis in the Respiratory Tract |
| 07/14/2011 | US20110171128 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
| 07/14/2011 | US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/14/2011 | US20110171126 Enhanced Cytotoxicity of Anti-CD74 and Anti-HLA-DR Antibodies with Interferon-Gamma |
| 07/14/2011 | US20110168170 Preservative free insulin formulations and systems and methods for aerosolizing |
| 07/14/2011 | US20110167602 Immunoneutral silk-fiber-based medical devices |
| 07/14/2011 | CA2823191A1 Apoe peptide dimers and uses thereof |
| 07/14/2011 | CA2822026A1 Saposin-a derived peptides and uses thereof |
| 07/14/2011 | CA2789972A1 Method for treatment of inflammatory disease and disorder |
| 07/14/2011 | CA2787054A1 Enhanced cytotoxicity of anti-cd74 and anti-hla-dr antibodies with interferon-gamma |
| 07/14/2011 | CA2786854A1 Method for treatment of inflammatory disease and disorder |
| 07/14/2011 | CA2786585A1 Methods and compositions for liquidation of tumors |
| 07/14/2011 | CA2786527A1 Biomatrices to attract and retain regenerative and reparative cells |
| 07/14/2011 | CA2786306A1 Methods and compositions for providing protective immunity in the elderly |
| 07/14/2011 | CA2785631A1 Method of use of stabilized plant-derived growth factor in skin care |
| 07/14/2011 | CA2785612A1 Ev576 for use in the treatment of viral infections of the respiratory tract |
| 07/14/2011 | CA2785595A1 Dry powder fibrin sealant |
| 07/14/2011 | CA2785594A1 Fibrinogen preparations enriched in fibrinogen with an extended alpha chain |
| 07/14/2011 | CA2784552A1 Treatment of nasal and sinus disorders |
| 07/14/2011 | CA2783555A1 Therapeutic uses of soluble alpha-klotho |
| 07/14/2011 | CA2781576A1 Combination preparation including a corticosteroid and exosomes |
| 07/14/2011 | CA2781223A1 Combination preparation including a cytokine antagonist and corticosteroid |
| 07/13/2011 | EP2343551A1 Disheveled PDZ modulators |
| 07/13/2011 | EP2343370A1 A throbin-like enzyme of agkistrodon acutus |
| 07/13/2011 | EP2343317A1 Apolipoprotein analogues |
| 07/13/2011 | EP2343316A1 Ligand binding site of RAGE and uses thereof |
| 07/13/2011 | EP2343315A2 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 07/13/2011 | EP2343314A2 Calcium fluoride phosphopeptide complexes |
| 07/13/2011 | EP2343311A2 Peptide inhibitors of HK2 and their use |
| 07/13/2011 | EP2343310A1 Serine hydrolase formulation |
| 07/13/2011 | EP2343308A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/13/2011 | EP2343285A2 Peptoid compounds |
| 07/13/2011 | EP2343085A2 Antibody against prostate stem cell antigen (PSCA) |
| 07/13/2011 | EP2343082A1 Oxyntomodulin for preventing or treating excess weight |
| 07/13/2011 | EP2343081A1 Interferon analogs |
| 07/13/2011 | EP2343080A1 PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN |
| 07/13/2011 | EP2343066A1 Therapeutic agent for hepatitis c |
| 07/13/2011 | EP2343062A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 07/13/2011 | EP2343060A1 Multi-layer controlled-release tablet comprising an active layer and one or more barrier layers |
| 07/13/2011 | EP2342356A2 Amyloid beta-peptides and methods of use thereof |
| 07/13/2011 | EP2342230A1 Materials and methods for inhibiting cancer cell invasion related to fgfr4 |
| 07/13/2011 | EP2342221A2 Methods for preparing purified polypeptide compositions |
| 07/13/2011 | EP2342213A1 Antimicrobial peptides |
| 07/13/2011 | EP2341985A1 Dental formulations for the prevention of dental erosion |
| 07/13/2011 | EP2341940A1 The stabilisation of proteins |
| 07/13/2011 | EP2341938A2 Use of an ang-(1-7) receptor agonist in acute lung injury |
| 07/13/2011 | EP2341927A2 Novel immunotherapy against several tumors including neuronal and brain tumors |
| 07/13/2011 | EP2341925A1 Composition of thrombolytic agent and anti thrombosis and also its production method |
| 07/13/2011 | EP2341924A2 Methods of treating hepatitis c virus infection |
| 07/13/2011 | EP2341923A2 Pharmaceutical composition comprising coenzyme q10 |
| 07/13/2011 | EP2341922A1 Complement proteins |
| 07/13/2011 | EP2341921A1 Antimicrobial peptides |
| 07/13/2011 | EP2341920A1 Antimicrobial peptides |